Anduril's rapid private-market valuation growth, driven by its May 2026 $5 billion Series H at $61 billion and subsequent secondary marks reaching $107–108 billion amid $2.2 billion in 2025 revenue and major contract wins including a potential $20 billion Army deal, underpins the 71.5% implied probability it surpasses Lockheed Martin's approximately $123 billion public market capitalization by December 31. Lockheed trades at roughly 1.6x sales with steady but slower defense prime dynamics, while Anduril benefits from investor enthusiasm for autonomous systems and AI-enabled platforms. Key near-term catalysts include Anduril's manufacturing expansions, potential further funding or IPO signals, and Lockheed's October earnings release, though private valuation volatility and dilution risks remain material factors in trader consensus.
基於Polymarket數據的AI實驗性摘要。這不是交易建議,也不影響該市場的結算方式。 · 更新於Anduril
Anduril
NPM Prices are published for trading days only and are updated once daily at 1:00 PM ET on the following calendar day.
If NPM has not published relevant data for the specified date by 1:00 PM ET on January 1, 2027, this market may remain open until 11:59 PM ET on January 4, 2027. If no further data is released by that time, the market will resolve according to the latest data available.
If NPM ceases publishing relevant data prior to the specified date, this market will resolve based on the NPM data published prior to the cessation of coverage, as well as applicable public market capitalization data following an IPO or direct listing.
If the private company completes an IPO or direct listing before the specified date, this market will resolve according to the company's public market capitalization at the market close of the specified date or the most recent trading day.
Public market capitalization will be determined using the final official regular-hours trading price published for the company's primary listed common equity on its primary exchange for the specified date or the most recent trading day, multiplied by the company's total outstanding common shares at the relevant time.
If a listed company merges with or acquires another entity and remains the parent company, no change to resolution methodology applies.
If a listed company is acquired, merges into another entity and is no longer the surviving parent company, or otherwise ceases to exist as an independent entity prior to the end of the period, only the NPM valuation and applicable public market capitalization achieved prior to completion of the transaction will be considered for resolution. No transaction, acquisition, or merger consideration will be considered for resolution.
The resolution source for the private company is NPM data published here (https://fe.secondmarket.com/companies/company-c62b8140-fdeb-428d-a9a6-d04eb3b24b49/data?return_url=https://polymarket.copilot.markets/finance/privates). The resolution source for any period following an IPO, direct listing, or relevant corporate action, will be official exchange trading data and publicly reported share counts.
If Anduril's valuation is equal to Lockheed Martin's public market capitalization at resolution, this market will resolve to 50-50.
Revisions to previously published NPM data made after their initial release will not be considered, unless made to correct clearly erroneous data.
市場開放時間: May 19, 2026, 4:25 PM ET
NPM Prices are published for trading days only and are updated once daily at 1:00 PM ET on the following calendar day.
If NPM has not published relevant data for the specified date by 1:00 PM ET on January 1, 2027, this market may remain open until 11:59 PM ET on January 4, 2027. If no further data is released by that time, the market will resolve according to the latest data available.
If NPM ceases publishing relevant data prior to the specified date, this market will resolve based on the NPM data published prior to the cessation of coverage, as well as applicable public market capitalization data following an IPO or direct listing.
If the private company completes an IPO or direct listing before the specified date, this market will resolve according to the company's public market capitalization at the market close of the specified date or the most recent trading day.
Public market capitalization will be determined using the final official regular-hours trading price published for the company's primary listed common equity on its primary exchange for the specified date or the most recent trading day, multiplied by the company's total outstanding common shares at the relevant time.
If a listed company merges with or acquires another entity and remains the parent company, no change to resolution methodology applies.
If a listed company is acquired, merges into another entity and is no longer the surviving parent company, or otherwise ceases to exist as an independent entity prior to the end of the period, only the NPM valuation and applicable public market capitalization achieved prior to completion of the transaction will be considered for resolution. No transaction, acquisition, or merger consideration will be considered for resolution.
The resolution source for the private company is NPM data published here (https://fe.secondmarket.com/companies/company-c62b8140-fdeb-428d-a9a6-d04eb3b24b49/data?return_url=https://polymarket.copilot.markets/finance/privates). The resolution source for any period following an IPO, direct listing, or relevant corporate action, will be official exchange trading data and publicly reported share counts.
If Anduril's valuation is equal to Lockheed Martin's public market capitalization at resolution, this market will resolve to 50-50.
Revisions to previously published NPM data made after their initial release will not be considered, unless made to correct clearly erroneous data.
Anduril's rapid private-market valuation growth, driven by its May 2026 $5 billion Series H at $61 billion and subsequent secondary marks reaching $107–108 billion amid $2.2 billion in 2025 revenue and major contract wins including a potential $20 billion Army deal, underpins the 71.5% implied probability it surpasses Lockheed Martin's approximately $123 billion public market capitalization by December 31. Lockheed trades at roughly 1.6x sales with steady but slower defense prime dynamics, while Anduril benefits from investor enthusiasm for autonomous systems and AI-enabled platforms. Key near-term catalysts include Anduril's manufacturing expansions, potential further funding or IPO signals, and Lockheed's October earnings release, though private valuation volatility and dilution risks remain material factors in trader consensus.
基於Polymarket數據的AI實驗性摘要。這不是交易建議,也不影響該市場的結算方式。 · 更新於



警惕外部連結哦。
警惕外部連結哦。
Frequently Asked Questions